Federal grants to The Hospital for Special Surgery Fund, Inc.
The Hospital for Special Surgery Fund, Inc. in New York, New York received $55.1 million in federal grants from fiscal 2021 to 2025, across 48 awards. Its largest program was Arthritis, Musculoskeletal and Skin Diseases Research, with $27.0 million. In fiscal 2025 it was awarded $13.8 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$55.1 million
- Awards48
- Awarded in FY 2025$13.8 million
- Largest award$4.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 24 | $9.6 million |
| FY 2022 | 27 | $9.9 million |
| FY 2023 | 26 | $11.5 million |
| FY 2024 | 25 | $10.4 million |
| FY 2025 | 28 | $13.8 million |
Programs that fund The Hospital for Special Surgery Fund, Inc.
| Program | Awards | Amount |
|---|---|---|
| Arthritis, Musculoskeletal and Skin Diseases Research | 28 | $27.0 million |
| Allergy and Infectious Diseases Research | 8 | $18.3 million |
| Aging Research | 4 | $4.1 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.2 million |
| Biomedical Research and Research Training | 1 | $1.6 million |
| Oral Diseases and Disorders Research | 1 | $831,820 |
| Trans-NIH Research Support | 3 | $579,258 |
| Military Medical Research and Development | 1 | $296,093 |
| National Center for Advancing Translational Sciences | 1 | $100,475 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 47 | $54.8 million |
| Department of Defense | 1 | $296,093 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Steroid therapy and cytokines in rheumatic diseases | Allergy and Infectious Diseases Research | March 25, 2021 | $4.7 million |
| Role of shh/brachyury axis in the maintenance of the postnatal intervertebral disc - project summary/ abstract the goal of this proposal is to identify the role of critical developmental molecules in growth and maintenance of the postnatal intervertebral disc (ivd, or disc), and how the loss of thes | Arthritis, Musculoskeletal and Skin Diseases Research | June 17, 2021 | $2.7 million |
| Role of developmental signaling pathways in maintenance of spinal discs - project summary/ abstract aging is a significant risk factor for the onset of several degenerative diseases, including spinal or intervertebral disc (IVD) degeneration and associated chronic back pain. Ivd degeneration and chr | Aging Research | August 13, 2021 | $2.7 million |
| Vascular quiescence and stabilization in immunity | Allergy and Infectious Diseases Research | December 4, 2020 | $2.6 million |
| Functional consequences of intergenic autoimmune disease risk variants - abstract systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by high morbidity and mortality, and largely ineffective treatments. Sle is genetically complex with strong familial aggregation and | Allergy and Infectious Diseases Research | March 3, 2023 | $2.5 million |
| Post-initiation control of transcription in inflammatory macrophages | Allergy and Infectious Diseases Research | November 13, 2020 | $2.4 million |
| Mechanisms controlling abc differentiation and function in sle - abstract abnormalities in b cell subsets play a key role in sle, a disease that, in addition to autoab production and multi-organ involvement, often includes upregulation of interferon stimulated genes (ISGS). One of the hallmarks of s | Arthritis, Musculoskeletal and Skin Diseases Research | May 11, 2022 | $2.3 million |
| Inhibition of STAT3 and inflammatory cytokine production | Allergy and Infectious Diseases Research | January 27, 2021 | $2.2 million |
| Glucocorticoid-regulated transcription networks in macrophage biology | Diabetes, Digestive, and Kidney Diseases Extramural Research | June 16, 2021 | $2.2 million |
| Cytokine regulation of ra synoviocyte phenotype | Arthritis, Musculoskeletal and Skin Diseases Research | July 12, 2021 | $1.9 million |
Questions people ask
How much federal grant money does The Hospital for Special Surgery Fund, Inc. get?
$55.1 million in 48 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives The Hospital for Special Surgery Fund, Inc. the most?
The Department of Health and Human Services, with $54.8 million in 47 awards. The Department of Defense follow.
What is The Hospital for Special Surgery Fund, Inc.'s largest federal grant?
$4.7 million under Allergy and Infectious Diseases Research, with its first action in the period on March 25, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund The Hospital for Special Surgery Fund, Inc.?
Its largest are Arthritis, Musculoskeletal and Skin Diseases Research, Allergy and Infectious Diseases Research and Aging Research.
Other grant recipients in New York
- Metropolitan Transportation Authority
- New York City Housing Authority
- Gateway Development Commission
- The Trustees of Columbia University in the City of New York
- Icahn School of Medicine at Mount Sinai
- New York University
- Inclusiv, Inc
- International Rescue Committee, Inc.
Largest federal grant recipients in New York · Federal grants in New York